Skip to Main Content

Paper Details

Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer.
Br J Cancer
16
2020
Author NameAffiliation
Hayley C WhitakerUniversity College London
  • 1 - 1

Datasets

Release 1.2